ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts that cover ACADIA Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $30.45, which forecasts a 49.85% increase in the stock price over the next year. The lowest target is $17 and the highest is $40.

Price Target: $30.45 (+49.85%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$17	$30.45	$32	$40
Change	-16.34%	+49.85%	+57.48%	+96.85%

Analyst Ratings

The average analyst rating for ACADIA Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	6	6	7	7	7	7
Buy	8	8	8	8	10	9
Hold	6	6	7	6	5	5
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	21	21	23	22	23	22

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $31 → $34	Buy	Maintains	$31 → $34	+67.32%	Mar 4, 2026
Ritu Baral TD Cowen	TD Cowen	Strong Buy Maintains $35 → $37	Strong Buy	Maintains	$35 → $37	+82.09%	Feb 26, 2026
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $31 → $30	Buy	Maintains	$31 → $30	+47.64%	Feb 26, 2026
Jason N. Butler Citizens	Citizens	Buy Maintains $34 → $35	Buy	Maintains	$34 → $35	+72.24%	Feb 26, 2026
Paul Matteis Stifel	Stifel	Hold Maintains $25 → $24	Hold	Maintains	$25 → $24	+18.11%	Feb 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.27B

Increased by 18.52%

from 1.07B

Revenue Next Year

1.41B

Increased by 11.34%

from 1.27B

EPS This Year

0.51

Decreased by -78.01%

from 2.30

EPS Next Year

1.00

Increased by 96.82%

from 0.51

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	484.15M	517.24M	726.44M	957.80M	1.07B	1.27B	1.41B
Revenue Growth	9.60%	6.83%	40.45%	31.85%	11.87%	18.52%	11.34%
EPS	-1.05	-1.34	-0.37	1.36	2.30	0.51	1.00
EPS Growth	-	-	-	-	69.12%	-78.01%	96.82%
Forward PE	-	-	-	-	-	40.17	20.41
No. Analysts	-	-	-	-	-	23	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.3B	1.5B
Avg	1.3B	1.4B
Low	1.2B	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	24.2%	21.2%
Avg	18.5%	11.3%
Low	9.8%	-2.9%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	1.12	2.04
Avg	0.51	1.00
Low	0.20	0.01

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-51.2%	302.7%
Avg	-78.0%	96.8%
Low	-91.5%	-98.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.